Improvement following correction of secondary mitral regurgitation in end-stage cardiomyopathy with mitral annuloplasty

American Journal of Cardiology

Volumn 78, Issue 8, 1996, Pages 966-969

  Bach, David S ^a,b   Bolling, Steven F ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

^b UNIVERSITY OF MICHIGAN   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; COHORT ANALYSIS; CONGESTIVE CARDIOMYOPATHY; CONGESTIVE HEART FAILURE; FEMALE; FOLLOW UP; HEART LEFT VENTRICLE FUNCTION; HUMAN; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE REGURGITATION; MORTALITY; TIME; TREATMENT OUTCOME;

CARDIOMYOPATHY, DILATED; COHORT STUDIES; FEMALE; FOLLOW-UP STUDIES; HEART FAILURE, CONGESTIVE; HUMANS; MALE; MIDDLE AGED; MITRAL VALVE; MITRAL VALVE INSUFFICIENCY; TIME FACTORS; TREATMENT OUTCOME; VENTRICULAR FUNCTION, LEFT;

EID: 0030587878     PISSN: 00029149     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9149(96)00481-X     Document Type: Article

References (19)

1. Boltwood CM, Tei C, Wong M, Shah PM. Quantitative echocardiography of the mitral complex in dilated cardiomyopathy: the mechanism of functional mitral regurgitation. Circulation 1983;68:498-508.
2. Kono T, Sabbah HN, Rosman H, Alam M, Jafri S, Goldstein S. Left ventricular shape is the primary determinant of functional mitral regurgitation in heart failure. J Am Coll Cardiol 1992;20:1594-1598.
3. Yellin EL, Yoran C, Frater RWM, Sonnenblick EH. Dynamics of acute experimental mitral regurgitation. In: Ionescu MI and Cohn LH, ed. Mitral Valve Disease: Diagnosis and Treatment. Boston, MA: Butterworth & Co. Publishers, 1985:11-25.
4. Romeo F, Pelliccia F, Cianfrocca C, Gallo P, Barilla F, Cristofani R, Reale A. Determinants of end-stage idiopathic dilated cardiomyopathy: a multivariate analysis of 104 patients. Clin Cardiol 1989;12:387-392.
5. Blondheim DS, Jacobs LE, Kotler MN, Costacurta GA, Parry WR. Dilated cardiomyopathy with mitral regurgitation; decreased survival despite a low frequency of left ventricular thrombus. Am Heart J 1991;122:763-771.
6. Hammermeister KE, Fisher L, Kennedy JW, Samuels S, Dodge HT. Prediction of late survival in patients with mitral valve disease from clinical, hemodynamic, and quantitative angiographie variables. Circulation 1978;57:341-349.
7. Phillips HR, Levine FH, Carter JE, Boucher CA, Osbakken MD, Okada RD. Akins CW, Daggett WM, Buckley MJ, Pohost OM. Mitral valve replacement for isolated mitral regurgitation: analysis of clinical course and late postoperative left ventricular ejection fraction. Am J Cardiol 1981;48;647-654.
8. Bolling SF, Deeb QM, Brunsting LA, Bach DS. Early outcome of mitral valve reconstruction in patients with end-stage cardiomyopathy. J Thorac Cardiovasc Surg 1995;109:676-683.
9. Bach DS, Boiling SF. Early improvement in congestive heart failure after correction of secondary mitral regurgitation in end-stage cardiomyopathy. Am Heart J 1995;129:1165-1170.
10. Spain MG, Smith MD, Grayburn PA, Harlamert EA, DeMaria AN. Quantitative assessment of mitral regurgitation by Doppler color flow imaging: angiographic and hemodynamic correlations. J Am Coll Cardiol 1989;13:585-590.
11. Douglas PS, Morrow R, Ioli A, Reichek N. Left ventricular shape, afterload and survival in idiopathic dilated cardiomyopathy. J Am Coll Cardial 1989;13:311-315.
12. D'Cruz IA, Shroff SG, Janicki JS, Jain A, Reddy HK, Lakier JB. Differences in the shape of the normal, cardiomyopathic, and volume overloaded human left ventricle. J Am Soc Echocardiogr 1989;2:408-414.
13. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, Gutgesell H, Reichek N, Suhn D, Schnittger J, Silverman NH, Tajik AJ. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989;2:358-367.
14. Lewis JF, Kuo LC, Nelson JG, Limacher MC, Quinones MA. Pulsed Doppler echocardiographic determination of stroke volume and cardiac output: clinical validation of two new methods using the apical window. Circulation 1984;70:425-431.
15. Dec GW, Fuster V. Idiopathic dilated cardiomyopathy. New Engl J Med 1994;331:1564-1575.
16. Stevenson LW, Fowler MB, Schroeder JS, Stevenson WQ, Dracup KA, Fond V. Poor survival of patients with idiopathic cardiomyopathy considered too well for transplantation. Am J Medicine 1987;83:871-876.
17. Likoff MJ, Chandler SL, Kay HR. Clinical determinants of mortality in chronic congestive heart failure secondary to idiopathic dilated or to ischemic cardiomyopathy. Am J Cardiol 1987;59:634-638.
18. Keogh AM, Baron DW, Hickie JB. Prognostic guides in patients with idiopathic or ischemic dilated cardiomyopathy assessed for cardiac transplantation. Am J Cardiol 1990;65:903-908.
19. The CONSENSUS Trial Study Group. Effects of enalopril on mortality in severe congestive heart failure. N Engl J Med 1987;316:1429-1435.